Annual report pursuant to Section 13 and 15(d)

Restatement of Previously Issued Financial Statements (Tables)

v3.22.2.2
Restatement of Previously Issued Financial Statements (Tables)
12 Months Ended
Dec. 31, 2021
Restatement of Previously Issued Financial Statements  
Summary of the effects of the restatement adjustments on each financial statement line item affected by the restatement as of the dates, and for the periods

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

As Previously

​

Network

​

Preferred Returns

​

Class A Units

​

Revenue

​

    

​

​

​

Reported

    

Adjustments

    

Adjustments

    

Adjustments

    

Adjustments

    

As Restated

Consolidated Balance Sheet as of December 31, 2020

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Health Plan Settlement Receivable

​

$

38,429,833

​

$

—

​

$

—

​

$

—

​

$

6,532,954

​

$

44,962,787

Total Current Assets

​

​

84,347,633

​

​

—

​

​

—

​

​

—

​

​

6,532,954

​

​

90,880,587

Total Assets

​

​

99,902,252

​

​

—

​

​

—

​

​

—

​

​

6,532,954

​

​

106,435,206

Class A Units Subject to Possible Redemption

​

​

—

​

​

—

​

​

—

​

​

43,656,270

​

​

—

​

​

43,656,270

Class D Units Subject to Possible Redemption

​

​

51,608,900

​

​

—

​

​

(4,567,346)

​

​

—

​

​

—

​

​

47,041,554

Contributed Capital

​

​

41,764,270

​

​

—

​

​

—

​

​

(41,764,270)

​

​

—

​

​

—

Class A Preferred Returns

​

​

3,815,034

​

​

—

​

​

(3,815,034)

​

​

—

​

​

—

​

​

—

Accumulated Equity-Based Compensation

​

​

1,368,567

​

​

—

​

​

—

​

​

(921,092)

​

​

—

​

​

447,475

Retained Loss from Non-Controlling Interests

​

 

(18,187,381)

​

 

18,187,381

​

​

—

​

​

—

​

​

—

​

 

—

Accumulated Deficit (formerly Accumulated Loss from Controlling Interest)

​

​

(126,242,225)

​

​

(18,187,381)

​

​

8,382,381

​

​

(970,908)

​

​

6,532,954

​

​

(130,485,179)

Total Member’s Deficit

​

​

(97,661,735)

​

​

—

​

​

4,567,346

​

​

(43,656,270)

​

​

6,532,954

​

​

(130,217,705)

Total Liabilities, Mezzanine Equity & Members' Equity (Deficit)

​

​

99,902,252

​

​

—

​

​

—

​

​

—

​

​

6,532,954

​

​

106,435,206

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Consolidated Statement of Operations for the Year Ended December 31, 2020

​

 

  

​

​

​

​

​

​

​

​

​

​

​

​

​

 

​

Capitated Revenue

​

$

471,551,241

​

$

—

​

$

—

​

$

—

​

$

9,188,336

​

$

480,739,577

Other Patient Service Revenue

​

​

13,990,050

​

​

—

​

​

—

​

​

—

​

​

(3,666,102)

​

​

10,323,948

Total Operating Revenue

​

​

485,541,291

​

​

—

​

​

—

​

​

—

​

​

5,522,234

​

​

491,063,525

Medical Expenses

​

​

485,513,143

​

​

—

​

​

—

​

​

—

​

​

(1,010,720)

​

​

484,502,423

Total Operating Expenses

​

​

520,661,923

​

​

—

​

​

—

​

​

—

​

​

(1,010,720)

​

​

519,651,203

Operating Loss

​

​

(35,120,632)

​

​

—

​

​

—

​

​

—

​

​

6,532,954

​

​

(28,587,678)

Interest Expense, net

​

​

(9,970,260)

​

​

—

​

​

7,437,080

​

​

—

​

​

—

​

​

(2,533,180)

Total Other Income (Expense)

​

​

(10,260,944)

​

​

—

​

​

7,437,080

​

​

—

​

​

—

​

​

(2,823,864)

Net Loss Attributable to Non-Controlling Interests

​

​

(4,307,071)

​

​

4,307,071

​

​

—

​

​

—

​

​

—

​

​

—

Net Loss (formerly Net Loss Attributable to Controlling Interests)

​

 

(41,074,505)

​

 

(4,307,071)

​

​

7,437,080

​

​

—

​

​

6,532,954

​

 

(31,411,542)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Consolidated Statements of Changes in Members' Deficit for the Year Ended December 31, 2020

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Preferred Return(s) at 8% (Class A + Class D Units)

​

$

7,437,080

​

$

—

​

$

(7,437,080)

​

$

—

​

$

—

​

$

—

Net Loss

​

​

(45,381,576)

​

​

—

​

​

7,437,080

​

​

—

​

​

6,532,954

​

​

(31,411,542)

Balance as of December 31, 2020

​

​

(97,661,735)

​

​

—

​

​

4,567,346

​

​

(43,656,270)

​

​

6,532,954

​

​

(130,217,705)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Consolidated Statements of Cash Flows for the Year Ended December 31 2020

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Net Loss

​

$

(45,381,576)

​

$

—

​

$

7,437,080

​

$

—

​

$

6,532,954

​

$

(31,411,542)

Health Plan Settlements Receivable/Premiums Receivable

​

​

(20,974,286)

​

​

—

​

​

—

​

​

—

​

​

(6,532,954)

​

​

(27,507,240)

Class A and Class D Preferred Returns

​

​

7,437,080

​

​

—

​

​

(7,437,080)

​

​

—

​

​

—

​

​

—

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Consolidated Balance Sheet as of December 31, 2019

​

 

  

​

 

​

​

​

​

​

​

​

​

​

​

​

 

​

Class A Units Subject to Possible Redemption

​

$

—

​

$

—

​

$

—

​

$

43,656,270

​

$

—

​

$

43,656,270

Class D Units Subject to Possible Redemption

​

​

47,556,622

​

​

—

​

​

(515,068)

​

​

—

​

​

—

​

​

47,041,554

Contributed Capital

​

​

41,764,270

​

​

—

​

​

—

​

​

(41,764,270)

​

​

—

​

​

—

Class A Preferred Returns

​

​

430,230

​

​

—

​

​

(430,230)

​

​

—

​

​

—

​

​

—

Accumulated Equity-Based Compensation

​

​

921,092

​

​

—

​

​

—

​

​

(921,092)

​

​

—

​

​

—

Retained Loss from Non-Controlling Interests

​

 

(13,880,310)

​

 

13,880,310

​

​

—

​

​

—

​

​

—

​

 

—

Accumulated Deficit (formerly Accumulated Loss from Controlling Interest)

​

​

(85,167,716)

​

​

(13,880,310)

​

​

945,297

​

​

(970,908)

​

​

—

​

​

(99,073,637)

Total Member’s Deficit

​

​

(55,932,434)

​

​

—

​

​

515,068

​

​

(43,656,271)

​

​

—

​

​

(99,073,637)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Consolidated Statement of Operations for the Year Ended December 31, 2019

​

 

  

​

 

​

​

​

​

​

​

​

​

​

​

​

 

​

Capitated Revenue

​

$

138,727,943

​

$

—

​

$

—

​

$

—

​

$

604,764

​

$

139,332,707

Other Patient Service Revenue

​

​

7,166,889

​

​

—

​

​

—

​

​

—

​

​

(1,017,484)

​

​

6,149,405

Total Operating Revenue

​

​

145,894,832

​

​

—

​

​

—

​

​

—

​

​

(412,720)

​

​

145,482,112

Medical Expenses

​

​

141,442,457

​

​

—

​

​

—

​

​

—

​

​

(412,720)

​

​

141,029,737

Total Operating Expenses

​

​

185,430,503

​

​

—

​

​

—

​

​

—

​

​

(412,720)

​

​

185,017,783

Interest Expense, net

​

​

(3,479,139)

​

​

—

​

​

945,297

​

​

—

​

​

—

​

$

(2,533,842)

Total Other Income (Expense)

​

​

(3,381,184)

​

​

—

​

​

945,297

​

​

—

​

​

—

​

​

(2,435,887)

Net Loss Attributable to Non-Controlling Interests

​

​

(7,907,592)

​

​

7,907,592

​

​

—

​

​

—

​

​

—

​

​

—

Net Loss (formerly Net Loss Attributable to Controlling Interests)

​

 

(35,009,263)

​

 

(7,907,592)

​

​

945,297

​

​

—

​

​

—

​

 

(41,971,558)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Consolidated Statements of Changes in Members' Deficit for the Year Ended December 31, 2019

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Preferred Return(s) at 8% (Class A + Class D Units)

​

$

945,298

​

$

—

​

$

(945,298)

​

$

—

​

$

—

​

$

—

Net Loss

​

​

(42,916,855)

​

​

—

​

​

945,297

​

​

—

​

​

—

​

​

(41,971,558)

Conversion of Debt to Class A Units

​

​

3,764,025

​

​

—

​

​

—

​

​

(3,764,025)

​

​

—

​

​

—

Class A Units Issued

​

​

11,184,468

​

​

—

​

​

—

​

​

(11,184,468)

​

​

—

​

​

—

Redemption of Class A Units

​

​

(15,000,000)

​

​

—

​

​

—

​

​

15,000,000

​

​

—

​

​

—

Modification of Class A

​

​

—

​

​

—

​

​

—

​

​

(1,892,002)

​

​

—

​

​

(1,892,002)

Balance as of December 31, 2019

​

​

(55,932,434)

​

​

—

​

​

515,068

​

​

(43,656,271)

​

​

—

​

​

(99,073,637)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Consolidated Statements of Cash Flows for the Year Ended December 31 2019

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Net Loss

​

$

(42,916,855)

​

$

—

​

$

945,297

​

$

—

​

$

—

​

$

(41,971,558)

Class A and Class D Preferred Returns

​

​

945,297

​

​

—

​

​

(945,297)

​

​

—

​

​

—

​

​

—

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Consolidated Statements of Changes in Members' Deficit for the Year Ended December 31, 2018

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Balance as of December 31, 2018

​

$

(13,868,589)

​

$

—

​

$

—

​

$

(41,815,530)

​

$

—

​

$

(55,684,119)